Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Posterior Capsule Opacification

Posterior Capsule Opacification

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Posterior Capsule Opacification

3 trials tracked for Posterior Capsule Opacification: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Other / NA 2
  1. Phase 4 Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy Completed
  2. N/A Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification Completed
  3. N/A Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313 Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Nd: YAG laser capsulotomy causes significant central macular thickness increase of 8.72 $\mu$m at week 1
Ophthalmology Meta-analysis
Nd: YAG laser capsulotomy causes significant central macular thickness increase of 8.72 $\mu$m at week 1 Laser treatment for cloudy lenses may affect eye tissue thickness
This meta-analysis of 23 studies involving 1,762 eyes evaluates Nd: YAG laser capsulotomy for posterior capsule opacification. The analysis …
New data shows that laser treatments used to clear clouded lenses can cause temporary swelling in the macula, a critical part of the eye.
Frontiers Jul 24, 2026
Hydrogels overcome physiological barriers to improve drug delivery and tissue repair in anterior segment diseases
Ophthalmology Sys. Review
Hydrogels overcome physiological barriers to improve drug delivery and tissue repair in anterior segment diseases Hydrogels Improve Drug Delivery for Various Eye Conditions
This systematic review evaluates hydrogel platforms including adhesive drops, thermosensitive gels, and drug-eluting lenses compared to conv…
New hydrogel technologies may overcome the limitations of standard eye drops to provide longer-lasting treatment for conditions like glaucom…
Frontiers Jul 8, 2026